Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Multiple Sclerosis

  Free Subscription


22.02.2010

1 Am J Hum Genet
2 Arch Phys Med Rehabil
1 Eur Neurol
2 J Neuroimmunol
2 J Neurol
2 Lancet Neurol
7 Mult Scler
1 Nat Rev Neurol
2 Neurology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hum Genet

  1. JAKKULA E , Leppa V, Sulonen AM, Varilo T, et al
    Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene.
    Am J Hum Genet. 2010;86:285-291.
    PubMed     Text format     Related articles    Abstract available


    Arch Phys Med Rehabil

  2. SCHULTHEIS MT , Manning K, Weisser V, Blasco A, et al
    Vision and Driving in Multiple Sclerosis.
    Arch Phys Med Rehabil. 2010;91:315-317.
    PubMed     Text format     Related articles    Abstract available

  3. GOVEROVER Y , O'Brien AR, Moore NB, Deluca J, et al
    Actual Reality: A New Approach to Functional Assessment in Persons With Multiple Sclerosis.
    Arch Phys Med Rehabil. 2010;91:252-260.
    PubMed     Text format     Related articles    Abstract available


    Eur Neurol

  4. MATSUI M , Tahara M, Tanaka M, Tanaka K, et al
    CD8CD11a(high) Cells Decreased in Multiple Sclerosis but Not in Neuromyelitis Optica.
    Eur Neurol. 2010;63:159-163.
    PubMed     Text format     Related articles    Abstract available


    J Neuroimmunol

  5. KARUSSIS D , Teitelbaum D, Sicsic C, Brenner T, et al
    Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available

  6. PIAZZA F , Difrancesco JC, Fusco ML, Corti D, et al
    Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available


    J Neurol

  7. IGNACIO RJ , Liliana P, Edgardo C
    Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available

  8. STEFFENSEN LH , Mellgren SI, Kampman MT
    Erratum to: Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis.
    J Neurol. 2010.
    PubMed     Text format     Related articles   


    Lancet Neurol

  9. STUVE O , Greenberg BM
    Anticipated benefits and surprising effects of daclizumab in multiple sclerosis.
    Lancet Neurol. 2010.
    PubMed     Text format     Related articles   

  10. WYNN D , Kaufman M, Montalban X, Vollmer T, et al
    Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
    Lancet Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available


    Mult Scler

  11. FINK F , Eling P, Rischkau E, Beyer N, et al
    The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  12. KIRA JI , Minohara M, Li W, Matsushita T, et al
    Authors' reply to Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica.
    Mult Scler. 2010.
    PubMed     Text format     Related articles   

  13. LANZILLO R , Orefice G, Quarantelli M, Rinaldi C, et al
    Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  14. QIU W , Bundell C, Wu JS, Castley A, et al
    Low level of systemic autoimmunity in Western Australian multiple sclerosis patients.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  15. PROSPERINI L , Leonardi L, De Carli P, Mannocchi ML, et al
    Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  16. INGRAM G , Colley E, Ben-Shlomo Y, Cossburn M, et al
    Validity of patient-derived disability and clinical data in multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available

  17. YADAV V , Marracci GH, Munar MY, Cherala G, et al
    Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available


    Nat Rev Neurol

  18. HANDEL AE , Giovannoni G, Ebers GC, Ramagopalan SV, et al
    Environmental factors and their timing in adult-onset multiple sclerosis.
    Nat Rev Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available


    Neurology

  19. HOFER S , Linnebank M, Weller M, Bahmanyar S, et al
    Cancer risk among patients with multiple sclerosis and their parents.
    Neurology. 2010;74:614-5.
    PubMed     Text format     Related articles   

  20. PENNY S , Khaleeli Z, Cipolotti L, Thompson A, et al
    Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
    Neurology. 2010;74:545-52.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.

   Design: